EUVIMEDEUVIMED entdecken
Crossref

Antibody-Mediated Depletion of Autoreactive T Lymphocytes through PD-1 Improves Disease Outcomes and Visualizes T Cell Activation in Experimental Autoimmune Encephalomyelitis

Connor Frank, Hannah E Salapa, Kevin J H Allen, Michael C Levin iD, Wojciech Dawicki iD, Ekaterina Dadachova

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2300751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Connor Frank und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Programmed Cell Death 1 Receptor, Lymphocyte Activation, Mice, Inbred C57BL. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Fedoruk Center for Nuclear Innovation, Saskatoon City Hospital Foundation (SCH Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term therapeutic outcomes of multiple sclerosis (MS) remain hindered by the chronic nature of immune cell stimulation toward self-antigens. Development of novel methods to target and deplete autoreactive T lymphocytes remains an attractive target for therapeutics for MS. We developed a programmed cell death 1 (PD-1)–targeted radiolabeled mAb and assessed its ability to deplete activated PD-1+ T lymphocytes in vitro and its ability to reduce disease burden of the myelin oligodendrocyte glycoprotein 35–55 experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice. We also investigated the upregulation of PD-1 on infiltrating lymphocytes in an animal model of MS. Finally, we demonstrate the (to our knowledge) first reported positron-emission tomography/computed tomography imaging of activated PD-1+ cells in the EAE animal model of MS. We found that the 177Lu radioisotope-labeled anti–PD-1 mAb demonstrated significant in vitro cytotoxicity toward activated CD4+PD-1+ T lymphocytes and led to significant reduction in overall disease progression in the EAE animal model. Our results show high expression of PD-1 on infiltrating lymphocytes in the spinal cords of EAE diseased animals. Positron-emission tomography/computed tomography imaging of the anti–PD-1 mAb demonstrated significant uptake in the cervical draining lymph nodes highlighting accumulation of activated lymphocytes. Targeted depletion of T lymphocytes using T cell activation markers such as PD-1 may present a novel method to reduce autoimmune attack and inflammation in autoimmune diseases such as MS. Development of multimodal nuclear theranostic agents may present the opportunity to monitor T cell activation via imaging radioisotopes and simultaneously treat MS using therapeutic radioisotopes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalProgrammed Cell Death 1 ReceptorLymphocyte ActivationMice, Inbred C57BLAnimalsMiceAntibodies, MonoclonalT-LymphocytesFemaleDisease Models, AnimalMultiple SclerosisPositron Emission Tomography Computed TomographyHumans

Substanzen

Programmed Cell Death 1 ReceptorAntibodies, MonoclonalPdcd1 protein, mouse

Autor:innen und Institutionen

  • College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Office of Saskatchewan Multiple Sclerosis Clinical Research Chair, Cameco MS Neuroscience Research Centre, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Neurology Division, Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Department of Anatomy, Physiology and Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Department of Biochemistry, Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

ORCID-Profile: Michael C Levin, Wojciech Dawicki

Förderung

  • Fedoruk Center for Nuclear Innovation
  • Saskatoon City Hospital Foundation (SCH Foundation)

Zitieren

APA

Frank, C., Salapa, H. E., Allen, K. J. H., Levin, M. C., Dawicki, W., & Dadachova, E. (2024). Antibody-Mediated Depletion of Autoreactive T Lymphocytes through PD-1 Improves Disease Outcomes and Visualizes T Cell Activation in Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300751

Vancouver

Frank C, Salapa HE, Allen KJH, Levin MC, Dawicki W, Dadachova E. Antibody-Mediated Depletion of Autoreactive T Lymphocytes through PD-1 Improves Disease Outcomes and Visualizes T Cell Activation in Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300751

BibTeX
@article{Frank2024,
  author = {Frank, Connor and Salapa, Hannah E and Allen, Kevin J H and Levin, Michael C and Dawicki, Wojciech and Dadachova, Ekaterina},
  title = {Antibody-Mediated Depletion of Autoreactive T Lymphocytes through PD-1 Improves Disease Outcomes and Visualizes T Cell Activation in Experimental Autoimmune Encephalomyelitis},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2300751}
}
Kostenlos starten →